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Effect of Fluid Resuscitation in Patients with ESRD and Sepsis or Septic Shock: An 
Integrative Review 
Currently, an estimated 1.5 million individuals are diagnosed with sepsis in the United 
States annually (CDC, 2020). Sepsis is a life-threatening organ dysfunction that is caused by 
body dysregulation as a response to infection (Rhodes et al., 2016). These infections are usually 
caused by a bacteria, fungus, or virus with the most common infections being pneumonia, 
abdominal infections, and kidney infections (Vaughan & Parry, 2016). Sepsis ranks as the 10th 
leading cause of death in the United States and is estimated to cost 20.3 billion healthcare costs 
annually (Abou Dagher et al., 2015; O’Brien, 2015). Sepsis accounts for almost 10% of all 
hospitalizations in the U.S. and remains to be one of the most expensive to treat (Rhee et al., 
2017).  
New evidence-based guidelines for sepsis management, developed by the Surviving 
Sepsis Campaign (SSC), lend hope of a comprehensive approach to early recognition and 
treatment (Rhodes et al., 2016; Dantes & Epstein, 2018; Makic & Bridges, 2018; Lehman & 
Thiessen, 2015; Nagalingam, 2018). The guidelines recommend a 30ml/kg intravenous (IV) 
crystalloid fluid bolus administered within the first three hours, obtaining blood cultures, both 
aerobic and anaerobic, measuring serum lactate levels, broad-spectrum IV antibiotic 
administration, and administration of vasopressors in treating hypotension and decreased organ 
perfusion (Vaughan & Parry, 2016; Singer et al., 2016). Initiating this treatment bundle allows 
clinicians to begin fluid resuscitation while obtaining more specific clinical information (Rhodes 
et al., 2016; Silva, Goncalves, & Sousa, 2018). 
The addition of a comorbidity such as end-stage renal disease (ESRD) or chronic kidney 
disease (CKD) increases the prevalence and morbidity rates of sepsis by 100-300 times (Abou 
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Dagher, 2015; Powe et al., 1999). Abou Dagher et al. (2015), found that 11.7% of hemodialysis 
patients and 9.4% of patients on peritoneal dialysis have experienced at least one episode of 
infection in the bloodstream and have an in-hospital mortality rate of 40% and a 28 day out of 
hospital mortality rate of 25%. 
Fluid resuscitation using a 30ml/kg IV crystalloid fluid bolus is a mainstay 
recommended treatment for patients diagnosed with sepsis. However, in patients with ESRD 
and CKD, this amount of fluid may be too much. The dilemma is these patients often present 
as fluid overloaded yet are hypotensive from intravascular depletion (Mcgloin, 2015; Marik et 
al. 2017). Fluid resuscitation in these patients is often limited because fluid overload is 
associated with increased mortality rates (Truong et al., 2019). The variable fluid status of 
patients with ESRD decreases compliance in the administration of this treatment (Truong et 
al., 2019; Jorgensen, 2019). Because of this, a diagnosis of sepsis may be mistreated, and 
patients may miss out on needed treatment methods.  
Background of problem 
In patients with ESRD, clinicians are tentative to initiate fluid resuscitation given the 
chance of negative outcomes associated with fluid overload. Given this, many ESRD patients 
with sepsis are severely under-resuscitated with fluids and experience a delay in receiving 
antibiotics (Abou Dagher et al. 2015). There is also controversy surrounding the type of fluid 
that should be used with patients with ESRD. The mainstay fluid for treatment is 0.9% 
sodium chloride solution (normal saline). Patient studies have found that this fluid could be 
harmful to the kidneys and should not be administered in patients with kidney disease 
(Rochwerg et al. 2015). This tentative treatment leads to decreased patient outcomes and 
slows the healing process. 
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The aim of this literature review is to synthesize the studies that explored fluid 
resuscitation in the management of ESRD patients diagnosed with sepsis. There are 
retrospective as well as quasi-experimental studies available for review on the treatment of 
sepsis and the treatment of ESRD patients diagnosed with sepsis. These articles will be 
analyzed, and a synthesis of research will be developed that focuses on best practice in 
treating ESRD patients diagnosed with sepsis or septic shock. This integrative review will 
help to understand the current literature on the problem and enable future research to be 
performed to improve overall knowledge and practice.  
Methods 
Aim 
The aim of this literature review was to review current studies examining the use of a 
fluid resuscitation bolus when treating patients diagnosed with sepsis or septic shock that have a 
history of ESRD. A synthesis of these studies was developed to inform practitioners on the best 
practice in treating these patients. 
Design 
 The integrative review methodology utilizes the Whittemore and Knafl (2005) approach to 
the integrative review process. Using this process, a diverse collection of articles was collected, 
synthesized, and presented. Proceeding through stages, articles were researched, evaluated using 
the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) research appraisal tool, analyzed 
for content and relevant themes, and discussed (Whittemore and Knafl, 2005).  
Search Strategy 
A comprehensive literature search was conducted using PubMed, CINAHL Plus, Medline 
Complete, Scopus, and Ebsco Host electronic databases. Key search terms included the terms 
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sepsis, septic shock, end-stage renal disease (ESRD), chronic kidney disease, fluid resuscitation, 
and fluid administration. Inclusion criteria for studies included (a) primary research and other 
integrative reviews that are peer-reviewed and focus on fluid resuscitation in patients with a 
history of end-stage renal disease or chronic kidney disease that have been diagnosed with sepsis 
or septic shock; (b) published from 2015 to 2020; (c) written in English; and (d) accessible in full 
text. Articles were excluded if they were: not primary research or integrative reviews focused on 
fluid resuscitation in patients with a history of end-stage renal disease or chronic kidney disease 
that have been diagnosed with sepsis or septic shock, published before 2015, not written in 
English, and not accessible in full text. Reference lists of relevant articles were used to identify 
additional articles that met the inclusion criteria. Articles were saved and categorized using 
Zotero reference management software.  
Search Outcome 
Based on the search strategy above, the initial search yielded 664 articles with duplicates 
removed. Of these 664 articles, 627 were excluded following a title search, leaving 37 articles to 
be assessed further. These 37 articles were further narrowed by reading the abstracts, leaving 15 
articles to be read in their entirety. As shown in Figure 1, the full article reviews found 10 
articles meeting inclusion criteria and appropriate appraisal level.   
Quality appraisal 
The 10 articles were analyzed using the JHNEBP research appraisal tool to justify their 
inclusion in the review. Two of the articles were literature reviews and were appraised as level V 
evidence with high-quality ratings. The remaining 8 articles were found to be non-experimental 
retrospective studies. They were appraised as level III evidence with 3 of the articles being of 
high quality and 5 of them being good quality.  
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Data reduction 
Utilizing the framework of Whittemore & Knafl (2005), information from the articles 
was coded and categorized. The articles were read and coded utilizing a color-coding strategy. 
Information between articles relating to the same topic was coded using a specific color to later 
synthesize. This allowed the identification of major themes across the articles.  
Results 
Main themes were identified throughout the article analysis. Table 2 delineates the 
themes that emerge. The three themes included: Timeliness of Fluid Administration, Volume of 
Fluids Administered and Secondary Outcomes. 
Timeliness of Fluid Administration 
The evidence-based guidelines developed for the SSC recommend administering 
30mL/kg of crystalloid fluids within the first three hours after recognizing the signs and 
symptoms of sepsis or septic shock (Rhodes et al., 2016; Dumont et al., 2016; Kleinpell, 
Eitken, & Schorr, 2013). This is a universal recommendation that is set for every patient. 
While this is the recommendation, it does not always occur in practice; various situations 
decrease compliance with this recommendation and cause a delay in fluid administration 
(Moreira & Sinert, 2020; Truong et al., 2019).  
Six of the articles had data comparing timeliness of fluid administration between 
patients with ESRD and patients without ESRD. By analyzing the selected articles, it was 
found that these delays are more common in patients with ESRD. The study by Kuttab et al. 
(2019) found that only 18% of the patients with ESRD in their study received the 30mL/kg 
fluid resuscitation bolus within three hours of presentation. This is mirrored in the study by 
Rajdev et al. (2020a) that found that only 23.08% of patients with ESRD received >30mL/kg 
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of fluid resuscitation within the first 6 hours of presentation. This is compared to 60.36% of 
patients without ESRD receiving >30mL/kg of fluid resuscitation in that same period.  
All studies that compared the timeliness of fluid administration between patients with 
ESRD, and those without ESRD, found disparities between the two groups. The patients with 
ESRD experienced a consistent delay in the administration of the recommended crystalloid 
fluid resuscitation bolus (Rajdev et al., 2020a; Kuttab et al., 2019; Lowe et al., 2017; Long, 
Koyfman, & Lee, 2017; Khan et al., 2020; Truong et al., 2019).  
Volume of Fluids Administered  
Like the findings on timeliness, the volume of fluids administered to patients with 
ESRD was also found to be lacking. Eight of the articles consistently found that patients with 
ESRD received a total volume of fluids that was less than the recommended amount (Rajdev 
et al., 2020a; Lowe et al. 2018; Khan et al., 2020; Truong et al., 2019; Long, Koyfman, & 
Lee, 2017; Rosa et al., 2017; Abou Dagher et al., 2015; Kuttab et al., 2019). When assessing 
the volume of fluids administered within six hours after patient presentation, Abou Dagher et 
al. (2015) found that patients with ESRD were administered an average of 0.58 liters of fluid. 
These findings were further investigated at the 24-hour mark following patient presentation 
with similar results. The patients with ESRD were administered an average of 1.27 liters of 
crystalloid fluid within this period. These findings are again continued in the study performed 
by Lowe et al. (2018) as they found that only 42% of ESRD patients with a diagnosis of 
sepsis were receiving 30mL/kg of crystalloid fluid within three hours. This same study found 
that 67% of patients without ESRD with a diagnosis of sepsis were meeting the SSC 
recommendation and receiving the proper amount of fluid within three hours.  
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In the literature reviews performed by Rosa et al. (2017) and Long et al. (2017), they 
found that fluid resuscitation should be performed with the same measurement and goals as 
patients without ESRD. They continued to find that these goals were not being met as the 
patients with ESRD were being under-resuscitated due to physician decision. While patients 
without ESRD were more commonly administered the recommended amount of fluids, 
patients with ESRD were not due to fear of fluid volume overload and pulmonary 
complications. Truong et al. (2019) found that providers are making individualized decisions 
regarding fluid resuscitation based on specific patient characteristics, such as a diagnosis of 
ESRD. For reasons such as these, it was found that patients with ESRD were not receiving the 
recommended amount of fluids and were often found to be hypovolemic with increased 
periods of hypotension (Truong et al., 2019; Abou Dagher et al., 2015; Rajdev et al., 2020a). 
Secondary Outcomes 
The third theme addresses the secondary outcomes of fluid resuscitation. The 
secondary outcomes of fluid resuscitation were attributed to several factors and are described 
in four subthemes: In-hospital Mortality, ICU LOS, Mechanical Ventilation Rates, and Need 
for Urgent Dialysis. Seven of the selected articles addressed at least one of the secondary 
outcomes.  
In-hospital Mortality 
Mortality rates were addressed in six articles. Four of the articles found that there was 
no significant difference in mortality rates between patients with ESRD that received 
30mL/kg of fluids versus patients that did not (Khan et al., 2020; Neyra et al., 2017; Rajdev et 
al., 2020b; Truong et al., 2019). In addition to these findings, two articles found that patients 
with ESRD who received the recommended amount of fluids experienced decreased mortality 
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rates when compared to those who did not (Kuttab et al., 2019; Rajdev et al., 2020a). These 
results show that the administration of a 30mL/kg fluid resuscitation bolus to patients with 
ESRD did not increase the overall in-hospital mortality, and in some cases, led to decreased 
mortality rates.  
ICU LOS 
ICU LOS was assessed in four articles. Like the mortality rate findings, the 
administration of a 30mL/kg fluid resuscitation bolus to patients with ESRD was not 
correlated with increased ICU LOS. Three of the articles found no significant difference 
between those who received the recommended amount of fluids and those who did not (Lowe 
et al., 2017; Rajdev et al., 2020a; Rajdev et al., 2020b). Kuttab et al., (2019) had findings like 
their findings on mortality rate. They found that patients who received the recommended 
amount of fluids experienced a decreased ICU LOS.  
Mechanical Ventilation 
Five of the articles discussed findings related to rates of mechanical ventilation. 
Overall, the findings found that the administration of a 30mL/kg fluid resuscitation bolus to 
patients with ESRD did not increase the rates of mechanical ventilation. In four of the studies, 
no significant difference in ventilation rates was found between patients that received the 
fluids and patients that did not (Khan et al., 2020; Lowe et al., 2017; Rajdev et al., 2020a; 
Rajdev et al., 2020b). Once again similar to other findings, Kuttab et al. (2019) found that the 
administration of the recommended amount of fluids was associated with decreased rates of 
mechanical ventilation in patients with ESRD.  
Need for Urgent Dialysis 
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Five of the articles discussed findings related to patients with ESRD requiring urgent 
dialysis as a result of fluid overload. Fluid overload is a leading concern that physicians have 
regarding patients with ESRD. Given the decreased kidney function, patients with ESRD 
receiving increased volumes of fluid over an extended period have been found to have an 
increased need for urgent dialysis and experienced negative patient outcomes (Neyra et al., 
2017). While fluid administration over an extended period of time was correlated with an 
increased need fur urgent dialysis, the five articles found no significant difference in rates of 
urgent dialysis in patients with ESRD who received a 30mL/kg fluid resuscitation bolus 
within six hours of presentation compared to those who did not (Khan et al., 2020; Kuttab et 
al., 2019; Neyra et al., 2017; Rajdev et al., 2020a; Rajdev et al., 2020b). These findings 
suggest that patients with ESRD presenting with sepsis or septic shock are often hypovolemic 
and can tolerate the increased fluid volumes with no significant differences in negative 
outcomes.  
Discussion 
Strengths and limitations 
Given the limited research performed on this specific topic, this integrative review has 
strength in that it synthesizes current and relevant studies. All studies were performed within 
the past five years and discussed information pertinent to this topic. Limitations include 
sample size, study design, and limited ways to limit confounding variables. The studies 
identified contained non-experimental, retrospective studies and other literature reviews. 
Given the variables being studied, nothing was being manipulated leaving the findings being 
observational. While many of the studies expressed limitations in sample size, study design, 
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and confounding variables, they were included because of the limited research that has 
currently been performed on this patient population.  
Implications 
These studies shed light on the treatment of patients with ESRD with a diagnosis of 
sepsis or septic shock. As discussed above, the recommended treatment guidelines for sepsis 
and septic shock do not vary based on patient-specific characteristics. It has been found that 
patients with ESRD have consistently been under resuscitated due to physician hesitance to 
initiate aggressive fluid resuscitation in a timely manner (Rajdev et al., 2020a; Lowe et al., 
2018; Khan et al., 2020; Truong et al., 2019; Long, Koyfman, & Lee, 2017; Rosa et al., 2017; 
Abou Dagher et al., 2015, Kuttab et al., 2019).  
The findings of this integrative review indicate that the administration of a 30mL/kg 
fluid resuscitation bolus to patients with ESRD within six hours of presentation is not harmful 
when treating sepsis or septic shock. The findings also suggest that this fluid resuscitation 
could improve patient outcomes given some findings suggesting decreased mortality rates, 
ICU LOS, and rates of mechanical ventilation.  
When analyzing articles for theme 1: Timeliness of Fluid Administration, 
 it was consistently found that patients with ESRD and a diagnosis of sepsis experience 
decreased timeliness of fluid administration. This data shows that there is area for 
improvement in meeting compliance with the SSC guidelines of administering the fluids 
within three hours of patient presentation (Rhodes et al., 2016).  
Theme 2: Volume of Fluids Administered, also showed that patients with ESRD also 
received lower volumes of fluids when compared to patients without ESRD. This again shows 
a decreased compliance with the SSC guidelines. While the reasons behind this are not 
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explicitly stated, the studies do suggest that it is safe for these patients to receive aggressive 
fluid therapy and receive the 30mL/kg fluid resuscitation bolus.  
Lastly, Theme 3: Secondary Outcomes assessed, provide data promoting the safety of 
fluid administration in these patients. Overall, the studies found no significant differences in 
mortality rates, ICU LOS, rates of mechanical ventilation, and rates of urgent dialysis. These 
findings suggest that the risk of fluid overload commonly associated with patients with ESRD 
is minimal and that fluid resuscitation should continue in the same manner and with the same 
goals as when treating patients without ESRD (Rosa et al., 2017).  
Conclusion 
The use of aggressive fluid therapy in patients with ESRD has been found to be 
controversial. Providers are having to choose between the risk of aggressive fluid therapy and 
the risk of worsening sepsis or septic shock. Having the comorbidity of ESRD regularly 
changes treatment plans as evidenced by the above studies. The importance of these studies is 
that it can influence the treatment plans of an entire group of people. While the number of 
included articles was small, they included findings that can help guide the treatment of 
patients with ESRD presenting with sepsis or septic shock. This information can help guide 
the clinical decision making of not only physicians, but also that of acute care nurse 
practitioners and advanced practice registered nurses (APRNs).  
It has also been made obvious that additional research needs to be conducted. Given 
the one size fits all SSC recommendation, further research needs to be performed exploring 
the treatment methods of patients of ESRD presenting with sepsis and septic shock. While this 
integrative review found themes relating to the timeliness of fluid administration, volume of 
fluids administered, and secondary outcomes, research needs to be performed to identify the 
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barriers leading to these shortcomings described. Increased research pertaining to the 
treatment of these patients can help millions. Studies with increased sample sizes would also 
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Figure 1 PRISMA flow diagram 
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be resuscitated with IV fluids as excess fluid can 
later be removed once sepsis has been treated.  
Retrospective study 
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Some patients did not have repeat vital 
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excess fluid is identified, it can later be removed.  
Limited patient-specific information 
provided. 















January 2014 and 
May 2016. Of 
these 137 had a 
comorbidity of 
ESRD.  
ESRD status is independently associated with lower 
fluid doses and compliance with the 30mL/kg fluid 
resuscitation goal within 3 hours. 
ESRD patients were 2.8 times less likely to meet the 
30mL/kg fluid resuscitation goal when compared to 
patients without ESRD.   
Retrospective study 
Only a small portion of the same had 
culture confirmation of infection 
Relatively small portion of ESRD 










2,632  patients 
admitted to an 
urban academic 
medical center 
ICU with severe 
sepsis or septic 
shock; 1211 of 
which with CKD 
Higher cumulative fluid balance at 72 hours of ICU 
admission was independently associated with 
hospital mortality regardless of CKD presence.  
Patients with CKD may have greater interstitial 
system adaptation to fluid overload. The compliance 
of the interstitial system can tolerate up to 4.5L of 
excess total body fluid before edema becomes 
evident on physical assessment. This may 
demonstrate chronic fluid overload adaptation.  
Data pertaining to fluid administration 
prior to ICU admission was not 
available. 
Possible over-classification of CKD 
due to determination of GFV values 
















Size, & setting 









215 adult patients 
admitted to a 
hospital with a 
discharge 
diagnosis of 
sepsis or septic 
shock.  
There was no significant difference in hospital LOS, 
ICU admission and LOS, need for urgent dialysis, 
intubation rates, and in-hospital mortality between 
the two case groups.  
There was no significant difference in secondary 
outcomes in the two subgroups of patients.  
The potential complication of fluid overload was not 
found between subgroup 1 and subgroup 2, with 
subgroup 2 receiving 43.4mL/kg of intravenous fluid 
within the first 6 hours.  
Single-center retrospective study 
 Only fluids were not studied, not 
other volume expanders or blood 
products 
APACHE scores were not recorded to 
measure severity of illness 
There was an inability to show any 
significant differences between the 










104 adult patients 





and/or HD  
There were no significant differences in duration of 
mechanical ventilation, in-hospital mortality, need 
for urgent dialysis, or hospital LOS in those who 
received <20mL/kg of fluids IV and those who 
received >20mL/kg of fluids IV. 
Patients who received <20mL/kg of fluids IV did not 
have worse outcomes than those who received 
aggressive fluid resuscitation.  
Single-center retrospective study 
Small sample population 
Only fluids were studied, not other 
volume expanders or blood products 
Did not evaluate APACHE scores to 

















Volume resuscitation in patients diagnosed with 
sepsis on long term renal replacement therapy (LT-
RRT) should proceed with the same volumes and 
goals as those not on LT-RRT. 













admitted to a 
community 
hospital with a 
diagnosis of 
sepsis between 
January 2015 and 
June 2016 
Non-compliance with the recommended fluid 
resuscitation of 30mL/kg was increased in patients 
with ESRD with only 42.3% receiving the 
recommended total volume  
 
Retrospective observational study 
Unmeasured confounding variables 
May have received lower total 
volumes of fluids due to lower 
severity of illness 
Unable to identify exact reasons 
regarding clinical decision making  
Identified no overall association of 
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Table 2: Themes and sub-themes 
Themes identified Subthemes identified Empirical sources 






Rajdev et al. (2020a), Kuttab et al. 
(2019), Lowe et al. (2017), Long, 
Koyfman, & Lee (2017), Khan et 
al. (2020), Truong et al. (2019) 
2) Volume of fluids administered (8) Rajdev et al. (2020a), Lowe et al. 
(2018), Khan et al. (2020), Truong 
et al. (2019), Long, Koyfman, & 
Lee (2017), Rosa et al. (2017), 
Abou Dagher et al. (2015), Kuttab 
et al. (2019). 
3) Secondary outcomes (7) a) In-hospital mortality 
(6) 
Khan et al. (2020), Kuttab et al. 
(2019), Neyra et al. (2017), Rajdev 
et al. (2020a), Rajdev et al. (2020b), 
Truong et al. (2019) 
b) ICU LOS (4) Kuttab et al. (2019), Lowe et al. 
(2017), Rajdev et al. (2020a), 
Rajdev et al. (2020b) 
c) Mechanical ventilation 
(5) 
Khan et al. (2020), Kuttab et al. 
(2019), Lowe et al. (2017), Rajdev 
et al. (2020a), Rajdev et al. (2020b) 
d) Need for urgent 
dialysis (5) 
Khan et al. (2020), Kuttab et al. 
(2019), Neyra et al. (2017) Rajdev 
et al. (2020a), Rajdev et al. (2020b) 
